Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Application of photothermal Optical Coherence Tomography (OCT) to detect macrophages in ex vivo rabbit arteries which have engulfed nanoclusters of gold coated iron oxide (nanorose) is reported. Nanorose engulfed by macrophages associated with atherosclerotic lesions in rabbit arteries absorb incident laser (800nm) energy and cause optical pathlength (OP) variation which is measured using photothermal OCT. OP variation in polydimethyl siloxane tissue phantoms containing varying concentrations of nanorose match values predicted from nanoparticle and material properties. Measurement of OP variation in rabbit arteries in response to laser excitation provides an estimate of nanorose concentration in atherosclerotic lesions of 2.5x10(9) particles/ml. OP variation in atherosclerotic lesions containing macrophages taking up nanorose has a different magnitude and profile from that observed in control thoracic aorta without macrophages and is consistent with macrophage presence as identified with RAM-11 histology staining. Our results suggest that tissue regions with macrophages taking up nanorose can be detected using photothermal OCT.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005175 | PMC |
| http://dx.doi.org/10.1364/BOE.1.000002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dual stimulus-responsive dECM cryogel sequentially regulate bone microenvironment for one-step surgical therapy of chronic osteomyelitis.
Mater Today Bio
October 2025
Department of Orthopedic Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, 515041, China.
Combining disinfection and bone regeneration in a one-step treatment is of significant clinical importance for chronic osteomyelitis, yet it remains a considerable challenge. To address this, we developed a dual stimulus-responsive decellularized extracellular matrix (dECM) cryogel (GC-dECM@CPN). The cryogel is composed of methacrylate gelatin (GelMA), carboxymethyl chitosan (CMCS), dECM, and temperature-sensitive phase-transition copper peroxide nanoparticles (CPNs).
View Article and Find Full Text PDFIntelligent hyaluronidase-responsive supramolecular nanoassemblies for programmable dual-drug delivery and NIR-II photothermal therapy of atherosclerosis.
Mater Today Bio
October 2025
School of Public Health, Key Laboratory of Emergency and Trauma of Ministry of Education, Hainan Medical University, Haikou, 571199, China.
The development of controllable nanoplatforms with disease-specific responsiveness and programmable therapeutic functions is vital for treating complex cardiovascular diseases such as atherosclerosis. Herein, we present an intelligent, next-generation nanoplatform (HALA@AgS) that integrates enzyme-responsive dual-drug delivery with NIR-II imaging-guided photothermal therapy (PTT), enabling triple-stimuli synergy of enzyme, light, and multi-drug co-activation. This modular design enables stable nanoassemblies with high drug-loading capacity and selective disassembly in enzyme-rich plaque microenvironments, achieving controlled dual-drug release exceeding 80 % within 72 h.
View Article and Find Full Text PDFA tumor microenvironment-responsive Zr-MOF nanosystem for co-delivering siHIF-1α and triptolide enhances photodynamic therapy in esophageal cancer by amplifying ROS generation and reversing hypoxia.
Mater Today Bio
October 2025
Department of Thoracic Surgery, The Shengjing Hospital of China Medical University, Shenyang, Liaoning, 110004, PR China.
In addition to early diagnosis and on-time treatment, the adoption of new therapeutic strategies is of great significance for improving the clinical outcomes of patients with esophageal cancer. Although emerging therapies such as photothermal and photodynamic therapy (PDT) can precisely eliminate cancer cells and are alternative strategies to conventional treatments, hypoxia status of solid tumors have hindered their application. In recent years, nanoplatforms have been developed to address these limitations and improve the efficacy and safety of treatments.
View Article and Find Full Text PDFA biomimetic nanoplatform for multimodal imaging-guided therapy of esophageal cancer via synergistic activation of cuproptosis and ferroptosis.
Mater Today Bio
October 2025
School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, 030001, PR China.
Esophageal cancer (EC) is a gastrointestinal malignancy with high morbidity and mortality. Traditional treatments yield unsatisfactory outcomes and novel intervention strategy is highly demanded. Cuproptosis and ferroptosis are recently defined modes of cell death, which displays promising utility in cancer treatment.
View Article and Find Full Text PDFRecent advances in copper sulfide nanoparticles for cancer diagnosis and therapy.
Mater Today Bio
October 2025
Department of Oncology, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Shenyang, 110042, China.
Cancer, a highly heterogeneous and complex disease characterized by multiple genetic and metabolic abnormalities, remains one of the leading causes of death worldwide. Although conventional treatments such as surgery, chemotherapy, and radiotherapy, can mitigate the disease to some extent, their efficacy remains constrained by various factors. In recent years, nanotechnology has emerged as a promising approach for cancer treatment, with copper-based nanomaterials garnering significant attention due to their unique physicochemical properties and favorable biocompatibility.
View Article and Find Full Text PDF